Epivir

Lamivudine

Developed to manage hiv infection and chronic hepatitis b to support long-term viral suppression.

Active ingredient
Lamivudine
Supply
Rx
Route
Oral use
Form
Film-coated tablet
Strengths
150mg

Epivir details

Alternative names
Epivir Hbv; Zeffix
Therapeutic class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Pharmacological class
Nucleoside analogue
Contraindications
hypersensitivity to lamivudine
Minor side effects
headache; nausea; fatigue
Moderate side effects
elevated liver enzymes; peripheral neuropathy
Dosage forms
Film-coated tablet
Administration route
Oral use
Supply category
Prescription only (specially controlled medicine)
Manufacturer
ViiV Healthcare
Onset Time
0.5–2 hours
Duration
12 hours
Storage instructions
Store at room temperature.
Drug interactions
trimethoprim; emtricitabine
Age restrictions
Dosage adjusted for children.
Precautions and warnings

regular blood monitoring recommended; inform your doctor if you experience liver issues

Serious side effects

lactic acidosis, requires immediate medical attention; severe hepatomegaly, requires immediate medical attention

Patient summary

Developed to manage hiv infection and chronic hepatitis b to support long-term viral suppression.

Mechanism of action

Lamivudine is a nucleoside analogue that inhibits human immunodeficiency virus (HIV) reverse transcriptase and hepatitis B virus DNA polymerase. It acts as a chain terminator, preventing successful viral DNA synthesis.

Pregnancy and breastfeeding

Pregnancy: Use as directed by an HIV specialist. Breastfeeding: HIV-positive mothers should generally avoid breastfeeding.

Where this medicine is registered

  • Singapore
  • Hong Kong
  • Thailand
  • Malaysia
  • Philippines
  • Indonesia
  • Taiwan
  • South Korea
  • Japan
  • Australia
  • New Zealand
  • UAE
  • South Africa

About Epivir

Epivir contains Lamivudine, an agent used for the management of HIV infection and chronic hepatitis B. This active ingredient is also distributed under brand names such as Epivir Hbv and Zeffix, which are produced by ViiV Healthcare. These are supplied as tablet forms in 150mg strengths for patients requiring consistent therapeutic support.

Epivir availability in Asia

Epivir is registered across 14 markets including South Korea, Japan and the UAE, with availability also in Singapore, Hong Kong and Thailand. Generic Lamivudine, much of it made in India, offers a more affordable alternative to the original brand, improving accessibility for expats and those living far from a well-stocked pharmacy. This medication is best used as part of a treatment plan overseen by a doctor.